AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Gemcitabine Hydrochloride Equivalent To Gemcitabine

15 registrations across 1 African market— 13 active

Markets with Gemcitabine Hydrochloride Equivalent To Gemcitabine

🇿🇦South Africa
15 registrations
13 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
GEMNIL 200 mg🇿🇦South AfricaSafeline Pharmaceuticals (Pty) LtdsuspendedNov 2023
GEMNIL 1 g🇿🇦South AfricaSafeline Pharmaceuticals (Pty) LtdsuspendedNov 2023
CERBIGEM 1🇿🇦South AfricaHetero Drugs South Africa (Pty) LtdactiveJan 1900
ONCOGEM 1000🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
MYLAN GEMCITABINE 1 g🇿🇦South AfricaViatris South Africa (Pty) LtdactiveJan 1900
MYLAN GEMCITABINE 200 mg🇿🇦South AfricaViatris South Africa (Pty) LtdactiveJan 1900
ROGEM 1🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
ROGEM 200🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
GEMCITABINE 1 g OETHMAAN🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
GEMCITABINE 200 mg OETHMAAN🇿🇦South AfricaOethmaan Biosims (Pty) LtdactiveJan 1900
GEMCITABINE 1g PHARMA-Q🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
GEMCITABINE ZYDUS 1 g🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
GEMCITABINE ZYDUS 200🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
GEMCITABINE 200 mg PHARMA-Q🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
ONCOGEM 200🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900

Gemcitabine Hydrochloride Equivalent To Gemcitabine in Africa — Regulatory Overview

Gemcitabine Hydrochloride Equivalent To Gemcitabine is registered across 1 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 13 (87%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.